Grazyna Kolacz-Swiderska

Kielce, SK 25406, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Adaptive Serum Biochemistry Responses to Ethanol Administration in a Mouse Model: Implications for Metabolic Regulation Under Analgesia.

Adaptive Serum Biochemistry Responses to Ethanol Administration in a Mouse Model: Implications for Metabolic Regulation Under Analgesia.

Journal: Molecules (Basel, Switzerland)

Published: October 12, 2025

Potential Benefits of Behaviors and Lifestyle for Human Health and Well-Being.

Potential Benefits of Behaviors and Lifestyle for Human Health and Well-Being.

Journal: Nutrients

Published: September 09, 2025

Effects of bortezomib on intracellular antioxidant and apoptosis in HepG2cells.

Effects of bortezomib on intracellular antioxidant and apoptosis in HepG2cells.

Journal: PeerJ

Published: October 03, 2024

Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome.

Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome.

Journal: Frontiers in oncology

Published: July 21, 2024

In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants.

In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants.

Journal: Genes

Published: February 17, 2024

Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment.

Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment.

Journal: Cancers

Published: August 23, 2023

The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma.

The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma.

Journal: Journal of clinical medicine

Published: February 10, 2023

Influence of Algae Supplementation on the Concentration of Glutathione and the Activity of Glutathione Enzymes in the Mice Liver and Kidney.

Influence of Algae Supplementation on the Concentration of Glutathione and the Activity of Glutathione Enzymes in the Mice Liver and Kidney.

Journal: Nutrients

Published: April 23, 2021

ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma.

ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma.

Journal: Frontiers in oncology

Published: September 25, 2018

TP53 polymorphism in plasma cell myeloma.

TP53 polymorphism in plasma cell myeloma.

Journal: Folia histochemica et cytobiologica

Published: March 24, 2017

Significance of Polymorphisms and Expression of Enzyme-Encoding Genes Related to Glutathione in Hematopoietic Cancers and Solid Tumors.

Significance of Polymorphisms and Expression of Enzyme-Encoding Genes Related to Glutathione in Hematopoietic Cancers and Solid Tumors.

Journal: BioMed research international

Published: July 23, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026